Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Immunomodulatory role of non-neuronal cholinergic signaling in myocardial injury.

Rocha-Resende C, Weinheimer C, Bajpai G, Adamo L, Matkovich SJ, Schilling J, Barger PM, Lavine KJ, Mann DL.

JCI Insight. 2019 Jun 4;5. pii: 128961. doi: 10.1172/jci.insight.128961.

2.

Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury.

Adamo L, Staloch LJ, Rocha-Resende C, Matkovich SJ, Jiang W, Bajpai G, Weinheimer CJ, Kovacs A, Schilling JD, Barger PM, Bhattacharya D, Mann DL.

JCI Insight. 2018 Jun 7;3(11). pii: 120137. doi: 10.1172/jci.insight.120137. eCollection 2018 Jun 7.

3.

Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.

Weinheimer CJ, Kovacs A, Evans S, Matkovich SJ, Barger PM, Mann DL.

Circ Heart Fail. 2018 May;11(5):e004351. doi: 10.1161/CIRCHEARTFAILURE.117.004351.

4.

TNF receptor-activated factor 2 mediates cardiac protection through noncanonical NF-κB signaling.

Evans S, Tzeng HP, Veis DJ, Matkovich S, Weinheimer C, Kovacs A, Barger PM, Mann DL.

JCI Insight. 2018 Feb 8;3(3). pii: 98278. doi: 10.1172/jci.insight.98278. eCollection 2018 Feb 8.

5.

Impact of pregnancy on autograft dilatation and aortic valve function following the Ross procedure.

Carvajal HG, Lindley KJ, Shah T, Brar AK, Barger PM, Billadello JJ, Eghtesady P.

Congenit Heart Dis. 2018 Mar;13(2):217-221. doi: 10.1111/chd.12554. Epub 2017 Dec 18.

PMID:
29250922
6.

Correction: Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.

Jia Y, Chang HC, Schipma MJ, Liu J, Shete V, Liu N, Sato T, Thorp EB, Barger PM, Zhu YJ, Viswakarma N, Kanwar YS, Ardehali H, Thimmapaya B, Reddy JK.

PLoS One. 2016 Sep 30;11(9):e0164316. doi: 10.1371/journal.pone.0164316. eCollection 2016.

7.

Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.

Jia Y, Chang HC, Schipma MJ, Liu J, Shete V, Liu N, Sato T, Thorp EB, Barger PM, Zhu YJ, Viswakarma N, Kanwar YS, Ardehali H, Thimmapaya B, Reddy JK.

PLoS One. 2016 Aug 22;11(8):e0160755. doi: 10.1371/journal.pone.0160755. eCollection 2016. Erratum in: PLoS One. 2016 Sep 30;11(9):e0164316.

8.

Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo.

Zhang W, Lavine KJ, Epelman S, Evans SA, Weinheimer CJ, Barger PM, Mann DL.

J Am Heart Assoc. 2015 Jun 2;4(6):e001993. doi: 10.1161/JAHA.115.001993.

9.

Regulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stress.

Ma X, Liu H, Murphy JT, Foyil SR, Godar RJ, Abuirqeba H, Weinheimer CJ, Barger PM, Diwan A.

Mol Cell Biol. 2015 Mar;35(6):956-76. doi: 10.1128/MCB.01091-14. Epub 2015 Jan 5.

10.

Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy.

Yang KC, Ma X, Liu H, Murphy J, Barger PM, Mann DL, Diwan A.

Circ Heart Fail. 2015 Jan;8(1):175-87. doi: 10.1161/CIRCHEARTFAILURE.114.001635. Epub 2014 Oct 22.

11.

Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury.

Tzeng HP, Evans S, Gao F, Chambers K, Topkara VK, Sivasubramanian N, Barger PM, Mann DL.

J Am Heart Assoc. 2014 Feb 26;3(1):e000662. doi: 10.1161/JAHA.113.000662.

12.

Tumor necrosis factor receptor-associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart.

Divakaran VG, Evans S, Topkara VK, Diwan A, Burchfield J, Gao F, Dong J, Tzeng HP, Sivasubramanian N, Barger PM, Mann DL.

Circ Heart Fail. 2013 May;6(3):535-43. doi: 10.1161/CIRCHEARTFAILURE.112.000080. Epub 2013 Mar 14.

13.

Myocardial recovery and the failing heart: myth, magic, or molecular target?

Mann DL, Barger PM, Burkhoff D.

J Am Coll Cardiol. 2012 Dec 18;60(24):2465-72. doi: 10.1016/j.jacc.2012.06.062. Epub 2012 Nov 14. Review.

14.

The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions.

Zhang W, Chancey AL, Tzeng HP, Zhou Z, Lavine KJ, Gao F, Sivasubramanian N, Barger PM, Mann DL.

Circulation. 2011 Nov 8;124(19):2106-16. doi: 10.1161/CIRCULATIONAHA.111.052399. Epub 2011 Oct 24.

15.

Therapeutic targeting of innate immunity in the failing heart.

Topkara VK, Evans S, Zhang W, Epelman S, Staloch L, Barger PM, Mann DL.

J Mol Cell Cardiol. 2011 Oct;51(4):594-9. doi: 10.1016/j.yjmcc.2010.11.003. Epub 2010 Nov 10. Review.

16.

Innate immunity in the adult mammalian heart: for whom the cell tolls.

Mann DL, Topkara VK, Evans S, Barger PM.

Trans Am Clin Climatol Assoc. 2010;121:34-50; discussion 50-1. Review.

17.

Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity.

Thakker GD, Frangogiannis NG, Zymek PT, Sharma S, Raya JL, Barger PM, Taegtmeyer H, Entman ML, Ballantyne CM.

Obesity (Silver Spring). 2008 Dec;16(12):2593-600. doi: 10.1038/oby.2008.414. Epub 2008 Oct 2.

18.

Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes.

Ramabadran RS, Chancey A, Vallejo JG, Barger PM, Sivasubramanian N, Mann DL.

Tex Heart Inst J. 2008;35(1):16-21.

19.

Inhibition of PPAR-alpha activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3.

Sekiguchi K, Tian Q, Ishiyama M, Burchfield J, Gao F, Mann DL, Barger PM.

Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1443-51. Epub 2006 Nov 10.

20.

Deranged energy substrate metabolism in the failing heart.

Tian Q, Barger PM.

Curr Hypertens Rep. 2006 Dec;8(6):465-71. Review.

PMID:
17087857
21.

Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.

Sano M, Wang SC, Shirai M, Scaglia F, Xie M, Sakai S, Tanaka T, Kulkarni PA, Barger PM, Youker KA, Taffet GE, Hamamori Y, Michael LH, Craigen WJ, Schneider MD.

EMBO J. 2004 Sep 1;23(17):3559-69. Epub 2004 Aug 5.

22.

Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure.

Sekiguchi K, Li X, Coker M, Flesch M, Barger PM, Sivasubramanian N, Mann DL.

Cardiovasc Res. 2004 Aug 15;63(3):433-42. Review.

PMID:
15276468
23.

Regulatory networks controlling mitochondrial energy production in the developing, hypertrophied, and diabetic heart.

Finck BN, Lehman JJ, Barger PM, Kelly DP.

Cold Spring Harb Symp Quant Biol. 2002;67:371-82. Review. No abstract available.

PMID:
12858562
24.

Has angiogenesis been invited to the PPARty?

Barger PM.

J Mol Cell Cardiol. 2002 Jul;34(7):713-6. No abstract available.

PMID:
12099711
25.
26.

PPAR signaling in the control of cardiac energy metabolism.

Barger PM, Kelly DP.

Trends Cardiovasc Med. 2000 Aug;10(6):238-45. Review.

PMID:
11282301
27.

Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP.

J Clin Invest. 2000 Oct;106(7):847-56.

28.

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.

Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP.

J Clin Invest. 2000 Jun;105(12):1723-30.

29.

Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms.

Barger PM, Kelly DP.

Am J Med Sci. 1999 Jul;318(1):36-42. Review.

PMID:
10408759
31.
33.

Rescue of blocked cells by reinnervation in denervated forelimb stumps of larval Ambystoma.

Olsen CL, Barger PM, Tassava RA.

Dev Biol. 1984 Dec;106(2):399-405.

PMID:
6500181

Supplemental Content

Loading ...
Support Center